Summary of Oncologic and Functional Outcomes
- PMID: 32351338
- PMCID: PMC7188505
- DOI: 10.1055/s-0039-3402778
Summary of Oncologic and Functional Outcomes
Abstract
Large cohort and collaborative studies to date have shown that the short-term oncological outcomes appear to be at least as good as traditional laparoscopic surgery. These results need confirmation in randomized controlled trials, which are currently underway (GRECCAR 11 and COLOR III). The functional data on transanal total mesorectal excision is still very scarce and more mature data on quality of life and function outcomes are eagerly awaited.
Keywords: functional outcome; laparoscopy; oncologic outcomes; randomized controlled trials; rectal cancer; taTME; total mesorectal excision; transanal total mesorectal excision.
© Thieme Medical Publishers.
Conflict of interest statement
Conflict of Interest None declared.
References
-
- Heald R J. A new approach to rectal cancer. Br J Hosp Med. 1979;22(03):277–281. - PubMed
-
- Quirke P, Durdey P, Dixon M F, Williams N S.Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision Lancet 19862(8514):996–999. - PubMed
-
- Heald R J, Husband E M, Ryall R D. The mesorectum in rectal cancer surgery--the clue to pelvic recurrence? Br J Surg. 1982;69(10):613–616. - PubMed
-
- Heald R J, Moran B J, Ryall R D, Sexton R, MacFarlane J K. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg. 1998;133(08):894–899. - PubMed
Publication types
LinkOut - more resources
Full Text Sources